Heart failure (HF)–exacerbating medications are commonly used in older adults hospitalized for HF and are often continued or even initiated after hospitalization, according to the results of an observational study published on November 8, 2019, in Journal of the American College of Cardiology.

Maria G. Tanzi, PharmDMaria G. Tanzi, PharmDMaria G. Tanzi, PharmDMaria G. Tanzi, PharmD

A recent event of patient-controlled analgesia (PCA) by proxy—a term used to describe conditions under which someone other than the patient administers one or more doses of an opioid to the patient using the PCA device—has prompted a review of the safeguards needed to prevent these types of events.

Maria Tanzi, PharmD

In October 2019, FDA approved rivaroxaban (Xarelto—Janssen) for venous thromboembolism (VTE) prophylaxis in acutely ill hospitalized patients at risk of forming blood clots but not at high risk of bleeding.

Aina Abell

Trending Topics in Health-System Pharmacy

Cancer. The diagnosis is terrifying and is often viewed as a death sentence. Most people valiantly fight against this disease, and some prevail.

Joey Sweeney, PharmD, BCPS